GLOBAL MASS SPECTROMETRY MARKET Rising focus on drug discovery and development
GROWTH MOMENTUM OF MASS SPECTROMETRY MARKET TO ACCELERATE Global mass spectrometry market contributes more than 14% share to the analytical instrument market Mass spectrometry (MS) is an analytical instrument that ionizes chemical species and sorts ions based on their mass-tocharge ratio. It is used in many different fields such as the pharmaceutical and chemical industries to analyze pure samples as well as complex mixtures.
THE MARKET IS FUELED BY RISING FOCUS ON DRUG DISCOVERY AND DEVELOPMENT A major driver for the growth of the mass spectrometry market is the rising focus on drug discovery and development. There is an increased focus on drug discovery and development by pharmaceutical and biotechnology companies as well as research institutes due to the rise in the prevalence of several chronic diseases globally.
The global mass spectrometry market is expected to grow at a CAGR of around 7% through 2022.
WORLD'S TOP BRANDS LEAD THE WAY The mass spectrometry market is characterized by numerous vendors. Agilent Technologies Bruker Danaher PerkinElmer Shimadzu Corporation Thermo Fisher Scientific Looking for more company info?
View Sample Page
https://www.technavio.com/report/global-mass-spectrometry-market-analysis-share-2018
THE AMERICAS ARE THE MASS SPECTROMETRY MARKET HUB Close to 42% of the overall market share comes from the Americas. By 2022, the Americas is expected to hold a 40.75% share. This will be due to the increasing awareness about the importance of MS and initiatives taken by governments to promote its use. Want to find out which countries are dominating the market?
View Report
https://www.technavio.com/report/global-mass-spectrometry-market-analysis-share-2018
INCREASING DEMAND FOR MASS SPECTROMETERS IN PERSONALIZED MEDICINE Personalized medicine, a multi-faceted approach to patient care, improves the ability to diagnose and treat diseases and also offers the potential to detect a disease at an earlier stage when it is easier to treat effectively.Â
$250 bn.
Estimates from healthcare commissions in the US have indicated an annual saving of $250-$300 billion on healthcare costs by 2023.
https://www.technavio.com/report/global-mass-spectrometry-market-analysis-share-2018
CONTACT US
North America
Europe
Chicago, USA Tel: +1 844 364 1100 Fax: +1 630 833 2171
London, United Kingdom Tel: +44 203 893 3200 Fax: +44 845 280 2825
enquiry@technavio.com http://www.technavio.com/
Asia Bangalore, India Tel: +91 803 927 6060 Fax: +91 806 690 2766